天大药业有限公司（00455）于2025年12月4日发布截至2025年11月30日的股份变动月报表。报告显示，该公司在本月并未进行新增发行、购回或注销等活动，整体股本保持不变。
公司月报表显示，法定注册股本仍为4,000,000,000股普通股，每股面值为0.1港元，总额4亿港元。已发行股份总数则维持在2,150,041,884股，截至报告期末没有持有任何库藏股。
公司本月未发生期权行使及股份购回与注销事项。月报同时披露，公司于2020年8月28日通过的购股权计划，潜在可发行或转让股份数目仍保持不变，并未本月新增行权。
截至2025年11月30日，天大药业整体股本结构保持稳定。根据公告，董事吕文生签署了该份月报，并确认公司遵守香港联交所上市规则及相关法律法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.